Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease.
The chronic inflammatory liver disease primary sclerosing cholangitis (PSC) is associated with portal inflammation and the development of neolymphoid tissue in the liver. More than 70% of patients with PSC have a history of inflammatory bowel disease and we have previously reported that mucosal addr...
Main Authors: | Grant, A, Goddard, S, Ahmed-Choudhury, J, Reynolds, G, Jackson, D, Briskin, M, Wu, L, Hübscher, S, Adams, D |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2002
|
Registos relacionados
-
Characterization of CCL21 expression in human secondary lymphoid organs and ectopic lymphoid tissues
Por: Bugatti, S, et al.
Publicado em: (2007) -
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis.
Por: Manzo, A, et al.
Publicado em: (2007) -
Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells
Por: Strieter Robert, et al.
Publicado em: (2003-11-01) -
CCL21 relationship with lymphoid neogenesis and lymphatic vascular system in chronically inflamed synovium
Por: Manzo, A, et al.
Publicado em: (2005) -
Chemokines and Innate Lymphoid Cells in Skin Inflammation
Por: Zhengwang Sun, et al.
Publicado em: (2021-11-01)